Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07054125

Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes

This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Type 2 Diabetes Mellitus - Poor Control

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Whole Endo

Asheville, North Carolina, 28801, United States

Location status: Recruiting

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years and older
  • Diagnosed with type 2 diabetes mellitus Hemoglobin A1c >8% Must have smartphone to connect with continuous glucose monitor

Exclusion criteria

  • Pregnancy Use of steroids Active cancer treatment Terminal illness Dementia, mental impairment Type 1 diabetes End stage renal disease, on dialysis

Treatment and study plan

Education, lifestyle counseling, and peer support

Behavioral

This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes.

People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).

Primary outcomes

  1. Hemoglobin A1c

    Time frame: 12 weeks

Study contacts

Contact information is provided by the study sponsor or research team.

Javier Samayoa, EdD

CONTACT

[email protected]

Rashim Gupta, MD

CONTACT

[email protected]

980-349-6036

Sponsors and collaborators

Lead sponsor

Whole Endo

Industry

Collaborators

  • DexCom, Inc.

Registry information

Official study title

The COMPASS Program: Continuous Monitoring, Peer And Structured Support for Management of Uncontrolled Type 2 Diabetes - A Prospective Single-Arm Study

Acronym: COMPASS

Important dates

Study start
2025
Primary completion
2027
Study completion
2028
First posted
Jul 8, 2025
Registry last updated
Jul 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.